Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Sage Therapeutics (SAGE) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Sage Therapeutics (SAGE) lobbying for?
Summary of Lobbying Data:
Company: Sage Therapeutics
Number of lobbying contracts: 10
Lobbying firms they hired: Llc, Avenue Solutions, W Strategies, Sage Therapeutics
General issues they lobbied on: Medicare/Medicaid, Health Issues
Specific issues they lobbied on:
– Readable Insurance Coverage Explanations Act (RICE Act)
– Bipartisan Safer Communities Act
– Affordable Insulin Now Act
– Issues related to the Senate Finance report on mental health and mental health legislation
– Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services
– Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP
– Senate Finance Committee bipartisan Discussion Draft: Mental Health Workforce
– Committee Print 117-1 – Improvements to Medicare Inpatient and Outpatient Mental Health Services (H.R. 8879, 2024)
– Education and awareness of mental health issues
– Consolidated Appropriations Act, including flexibilities to prescribe controlled substances via telehealth
– Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs, particularly postpartum depression
– S. 3700/H.R. 6833, expanding home and community based services, and extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31
– Restoring Hope for Mental Health and Well-Being Act of 2022
– Issues related to reauthorization of FDA user fee bills (H.R.7667)
– Better Health Care Directories Act (H.R. 8886)
– Senate drug pricing provisions and Medicare Part D reforms in reconciliation language
– Telehealth Medicare physician reimbursement
– H.R.4058/S.2061 – Telemental Health Care Access Act of 2021 to remove barriers to telemental health services for Medicare beneficiaries.
– The Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types.
Government agencies they lobbied: Senate, Centers For Medicare and Medicaid Services (CMS), House of Representatives
One could infer that Sage Therapeutics is lobbying on these health-related issues to influence government policies and regulations that will benefit the company’s business interests. As a biotechnology company, Sage Therapeutics focuses on developing treatments for central nervous system disorders such as depression and postpartum depression. Therefore, lobbying efforts to improve mental health legislation, expand access to mental health services, and lower prescription drug costs would benefit the company’s product development and market potential. Additionally, lobbying to improve Medicare and Medicaid policies could increase patient access to these treatments, further benefiting the company’s bottom line.
